Exelixis
EXEL
#1553
Rank
โ‚น956.70 B
Marketcap
โ‚น3,418
Share price
1.49%
Change (1 day)
83.92%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Market capitalization of Exelixis (EXEL)

Market cap: โ‚น956.70 Billion

As of March 2025 Exelixis has a market cap of โ‚น956.70 Billion. This makes Exelixis the world's 1553th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Exelixis from 2000 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น956.70 B15.5%
2024โ‚น828.30 B33.37%
2023โ‚น621.05 B45.06%
2022โ‚น428.13 B-0.55%
2021โ‚น430.49 B-5.46%
2020โ‚น455.37 B19.28%
2019โ‚น381.78 B-7.43%
2018โ‚น412.44 B-28.18%
2017โ‚น574.27 B95.49%
2016โ‚น293.75 B243.81%
2015โ‚น85.44 B377.9%
2014โ‚น17.87 B-74.42%
2013โ‚น69.88 B52.04%
2012โ‚น45.96 B35.37%
2011โ‚น33.95 B-15.54%
2010โ‚น40.20 B8.94%
2009โ‚น36.90 B44.84%
2008โ‚น25.47 B-28.18%
2007โ‚น35.47 B-7.28%
2006โ‚น38.26 B8.22%
2005โ‚น35.35 B14.59%
2004โ‚น30.85 B34.83%
2003โ‚น22.88 B0.45%
2002โ‚น22.78 B-49.4%
2001โ‚น45.02 B41.16%
2000โ‚น31.89 B

End of Day market cap according to different sources

On Mar 10th, 2025 the market cap of Exelixis was reported to be:

โ‚น956.70 Billion
by Yahoo Finance info icon info icon
โ‚น956.70 Billion
by CompaniesMarketCap info icon info icon
โ‚น956.71 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
โ‚น7.171 T 649.61%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น12.990 T 1,257.83%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚น21.000 T 2,095.10%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น11.180 T 1,068.65%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น15.352 T 1,504.74%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น35.248 T 3,584.35%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น13.180 T 1,277.69%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น2.06 B-99.78%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น45.52 B-95.24%๐Ÿ‡บ๐Ÿ‡ธ USA